{
  "id": 19674722,
  "title": "Amdocs director Sarah Davis buys $35,127 in shares",
  "url": "https://urgent.news/2026/11/12/amdocs-director-sarah-davis-buys-35-127-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-12T16:31:21.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/amdocs-director-sarah-davis-buys-35127-in-shares-93CH-5022729"
  },
  "original_language": "en",
  "account": "Amdocs director Sarah Davis increased her stake in the company by purchasing 822 shares of Amdocs Ltd. (DOX) at a price of $42.7341 per share on November 9, 2026, according to the company's latest insider transaction report. This brought her total direct ownership of ordinary shares to 23,368. Separately, Davis received 6,058 shares as part of a grant with no cost attached. This transaction comes as Amdocs shares have declined by 45% year-to-date, trading at $44.46. Despite the recent drop, analysts suggest the stock is undervalued at its current price. Amdocs has been actively buying back shares, a practice highlighted among 12+ exclusive insights for investors. The company also provides a solid dividend yield of 5.28%. Recent fiscal data shows Amdocs reported $4.7 billion in revenue for fiscal 2026, marking a 3.6% increase, and non-GAAP earnings per share of $7.41, a 6% rise, both meeting expectations. However, the company anticipates a decline in revenue and profit for fiscal 2027 due to a dispute with major customer T-Mobile, leading to a downgrade of Amdocs' stock rating by Oppenheimer.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}